Rocuronium Bromide Injection
Product Images NDC 43547-531

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 43547-531). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
FDA Label Image

Figures 1 (Image 02)

Figures 1 (Image 02)
FDA Label Image

Figure 2 (Image 03)

Figure 2 (Image 03)
This appears to be a chart or graph showing the number of minutes against different dosages for different age groups. The age group ranges from 3 months to over 65 years old. The dosages are measured in mg/kg. It seems that the graph is displaying the amount of time for the medication to take effect (in minutes) for different age groups and dosages.*
FDA Label Image

Figure 3 (Image 04)

Figure 3 (Image 04)
FDA Label Image

50 mg/5 mL Vial (Image 05)

50 mg/5 mL Vial (Image 05)
Rocuronium Bromide Injection is a sterile and non-pyrogenic medication intended for intravenous use only. The medication is contained in a multi-dose vial with 50mg/5ml concentration (10mg/mL) and has the NDC code 43547-530-01. The text also includes various alphanumeric codes and symbols which do not provide any additional information about the medication.*
FDA Label Image

50 mg/5 mL Carton (Image 06)

50 mg/5 mL Carton (Image 06)
FDA Label Image

Peel Off Label 10 mg/ml (Image 07)

Peel Off Label 10 mg/ml (Image 07)
FDA Label Image

100 mg/10 mL Vial (Image 08)

100 mg/10 mL Vial (Image 08)
This product is a 100mg/10mL injection of Rocuronium Bromide. It is a sterile and nonpyrogenic solution made available in a multi-dose vial. The product is intended for intravenous (IV) use only and is used as a paralyzing agent that may cause respiratory arrest. The use of artificial respiration should be made to facilitate breathing in such cases. This product is available immediately for use in facilities.*
FDA Label Image

100 mg/10 mL Carton (Image 09)

100 mg/10 mL Carton (Image 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.